Clik here to view.
Appeals court upholds Patent Office’s invalidity ruling on J&J stents patent
A federal appeals court yesterday upheld a patent board decision invalidating portions of a Johnson & Johnson (NYSE:JNJ) patent covering drug-eluting stents in a case that dates back to 2009....
View ArticleClik here to view.
Scientists develop silver-releasing scaffold to prevent MRSA infection in bone
Researchers have developed a biocompatible, silver-releasing scaffold that inhibits methicillin-resistant Staphylococcus aureus, MRSA, infection in bone. The team’s work was published in Tissue...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 4, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Flashback Technologies wins de novo FDA nod for blood loss algorithm
Predictive data analytics company Flashback Technologies said today it won FDA de novo clearance for devices using its Compensatory Reserve Index algorithm, now cleared as an adjunctive cardiovascular...
View ArticleClik here to view.
MassDevice Q&A: Greenberg Traurig’s Lori Cohen on defending product liability...
When it comes to defending product liability lawsuits, it’s tough to top Greenberg Traurig’s Lori Cohen and her 96.6% winning percentage – she’s 56-for-58 lifetime in the courtroom.* Cohen, a...
View ArticleClik here to view.
EarlySense wants to get its mobile health sensor into your home
[Image courtesy of EarlySense]Health monitor company EarlySense is expanding into the consumer space. The Waltham, Mass.–based company announced Tuesday that is has created a contact-free consumer...
View ArticleClik here to view.
Solera Health raises $5m
Solera Health raised $5 million in a new round of equity financing, according to an SEC filing posted this week. Solera’s technology platform is designed to connect patients and physicians with...
View ArticleClik here to view.
Abbott closes $25B St. Jude buy
Abbott (NYSE:ABT) said today it closed its $25 billion buy of St. Jude Medical (NYSE:STJ), permanently tying up the 2 major medtech players. Under the merger agreement, St. Jude Medical will now be a...
View ArticleClik here to view.
Swiss Competent Authority weighs in on medical device firms “orphaned” by...
By Stewart Eisenhart, Emergo Group A second European Competent Authority, the Swiss Agency for Therapeutic Products (Swissmedic), has now addressed the burgeoning issue of medical device manufacturers...
View ArticleClik here to view.
Apligraf cell therapy changes genomic profile of chronic wound
Organogenesis Inc. said yesterday that its wound-healing cell therapy Apligraf is the 1st of its kind to significantly change the genomic profile of a treated chronic wound. The claim was supported by...
View ArticleClik here to view.
Clearside Biomedical names Beckman as new CMO | Personnel Moves, Jan. 5, 2017
Clearside Biomedical (NSDQ:CLSD) today named Dr. Richard Beckman as chief medical officer. The ophthalmologist has 13 years of clinical practice under his belt, as well as 20 years of corporate...
View ArticleClik here to view.
Sofar puts another $5m into TransEnterix
TransEnterix (NYSE:TRXC) said today that Italy’s Sofar SpA agreed to buy a $5 million stake in lieu of a $10 million milestone payment as the duo amended the $100 million deal for Sofar’s Telelap ALF-X...
View ArticleClik here to view.
Cerêve lands $38m Series B for insomnia device
Cerêve Inc., said today that it closed a$38 million Series B found, led by global investment firm KKR. Other investors included Versant Ventures, Arboretum Ventures and Partner Ventures. The company is...
View ArticleClik here to view.
Keystone Nano wins FDA nod for nanoliposome cancer treatment
Keystone Nano said today that the FDA approved its investigational new drug application for the ceramide nanoliposome as a treatment for solid tumors. The company will launch a phase I trial at 3 sites...
View ArticleClik here to view.
Neurelis closes Series B for intranasal diazepam spray
Neurelis, Inc. said today that it closed a Series B financing round, led by HBM Healthcare Investments. Other investors included LYZZ Capital, which previously led a Series A funding round for the...
View ArticleClik here to view.
AirXpander’s AeroForm tissue expander transforms decades-old procedure
For 40 years, plastic surgeons have used saline injections to expand tissue and prepare patients for breast implants following mastectomies. These tissue expanders consist of a silicone shell with a...
View ArticleClik here to view.
Exact Imaging raises $16m in Series C to support ExactVu micro-ultrasound
Micro-ultrasound developer Exact Imaging said today it raised $16.3 million (CDN $21.5 million) in a Series C funding round, with funds slated to support the commercialization of its ExactVu...
View ArticleClik here to view.
Intuity Medical adds $15m to Series C for Pogo glucose meter
Intuity Medical said today that it added another $15 million to the $40 million Series C round it reported late last year, bringing the round’s total to $55 million. Sunnyvale, Calif.-based Intuity...
View ArticleClik here to view.
Luminex wins FDA nod to test for dangerous pregnancy infection
Luminex Aries GBS assay [Image courtesy of Luminex]Luminex continues to rack up FDA clearances for assays to use in its Aries systems. The Austin, Texas–based company said Wednesday that FDA has...
View ArticleClik here to view.
Mazor Robotics gains on Street-beating Q4 outlook
Mazor Robotics (NSDQ:MZOR) said today that it expects its 4th-quarter revenues to top expectations on Wall Street, sending share prices up in mid-day trading. The Caesarea, Israel-based robot-assisted...
View Article
